| Patents for C07D 495 - Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms (21,336) |
|---|
| 04/29/2004 | WO2003097649A3 1-oxa-dibenzoazulenes as inhibitors of tumor necrosis factor production and intermediates for the preparation thereof |
| 04/29/2004 | WO2002085909A8 9-deazaguanine derivatives as inhibitors of gsk-3 |
| 04/29/2004 | US20040082789 Thieno[2,3-c]iosquinolines for use as inhibitors of parp |
| 04/29/2004 | US20040082639 Antitumor agents; restenosis; antiarthritic agents; antidiabetic agents |
| 04/29/2004 | US20040082635 Fused cyclic compounds and medicinal use thereof |
| 04/29/2004 | US20040082609 PGD2 receptor antagonists for the treatment of inflammatory diseases |
| 04/29/2004 | US20040082607 Fused heterocyclic compounds |
| 04/29/2004 | US20040082592 Metabotropic glutamate receptor antagonists |
| 04/29/2004 | US20040082573 Anxiolytic agents with reduced sedative and ataxic effects |
| 04/29/2004 | CA2502516A1 Anthelmintic and insecticidal thiophene compositions |
| 04/28/2004 | EP1413576A2 Substituted imidazole derivatives having agonist-like activity at alpha 2B or 2B/2C adrenergic receptors |
| 04/28/2004 | EP1412364A1 Platelet adp receptor inhibitors |
| 04/28/2004 | EP1412362A1 Chemical compounds |
| 04/28/2004 | EP1412348A1 Compounds derived from diaminopyrazole substituted by a heteroaromatic radical and their use in oxidation dyeing of keratinous fibres |
| 04/28/2004 | EP1411942A1 Substituted anilinic piperidines as mch selective antagonists |
| 04/28/2004 | EP1411932A1 Substituted oxazolidinones for combinational therapy |
| 04/28/2004 | EP1411928A1 Viral polymerase inhibitors |
| 04/27/2004 | US6727271 Oxazole or thiazole derivatives; antilipemic agents, hypotensives, antineoplastic agents |
| 04/27/2004 | US6727264 Substituted anilinic piperidines as MCH selective antagonists |
| 04/27/2004 | US6727258 Allosteric adenosine receptor modulators |
| 04/27/2004 | US6727251 Inhibitors of glycogen synthase kinase-3 (gsk-3) and aurora-2, both serine/threonine protein kinases; for treating diseases such as cancer, diabetes and alzheimer's disease |
| 04/22/2004 | WO2004033397A2 Activity-based probes, and methods of their preparation and use |
| 04/22/2004 | WO2004032848A2 Pgd2 receptor antagonists for the treatment of inflammatory diseases |
| 04/22/2004 | US20040077664 Pharmaceutical formulation comprising pyrazolo[4,3-d]pyrimidine and nitrates or thienopyrimidines and nitrates |
| 04/22/2004 | US20040077663 Thienopyrimidine-based inhibitors of the src family |
| 04/22/2004 | US20040077643 3,4 Dihydroisoquinoline derivative compounds and drugs containing these compounds as the active ingredient |
| 04/22/2004 | US20040077630 Allosteric adenosine receptor modulators |
| 04/22/2004 | US20040077606 Anticancer, antiangiogenic agents; such as imidazo(1,5-a)-pyrazine-1,3-dione derivatives |
| 04/22/2004 | US20040077605 Cancer, immune disorders; such as 6-hydroxy-4-methyl-1,3-dioxo-4,7-epoxy-2H-isoindol-2-yl)-2-(trifluoromethyl)-benzonitrile |
| 04/22/2004 | CA2501831A1 Activity-based probes, and methods of their preparation and use |
| 04/22/2004 | CA2500582A1 Pgd2 receptor antagonists for the treatment of inflammatory diseases |
| 04/21/2004 | EP1409491A2 Thienopyrimidine-based inhibitors of the src family |
| 04/21/2004 | EP1409485A1 Novel immunomodulating compounds |
| 04/21/2004 | EP1409476A1 Pharmaceutical compounds with serotonin receptor activity |
| 04/21/2004 | CN1491225A Tricyclic and heterocyclic derivative compounds and drugs containing these compounds as active ingredient |
| 04/21/2004 | CN1491208A Acylated 6,7,8,9-tetrahydro-5H-benzocycloheptenyl amines and their use as pharmaceutical |
| 04/21/2004 | CN1491207A Acylated indanyl amines and their use as pharmaceuticals |
| 04/21/2004 | CN1146567C 奥氮平二水合物d Olanzapine dihydrate d |
| 04/21/2004 | CN1146422C 2-methyl-thieno-benzodiazepine formulation |
| 04/21/2004 | CN1146421C Composition for treating pains and use of medicines in preparation thereof |
| 04/20/2004 | US6723859 Chromene compound |
| 04/20/2004 | US6723722 Acylhydrazine derivatives, their production and use |
| 04/20/2004 | CA2256479C Novel photochromic heterocyclic fused indenonaphthopyrans |
| 04/15/2004 | WO2004031194A1 Process and intermediates for the preparation of the thienopyrrole derivatives |
| 04/15/2004 | WO2004031193A1 Process and intermediates for the preparation of thienopyrrole derivatives |
| 04/15/2004 | WO2004031192A1 3,4-alkylenedioxythiophene compounds and polymers thereof |
| 04/15/2004 | WO2004031169A1 Antibacterial agent having thiophene skeleton |
| 04/15/2004 | WO2002083111A3 Imidazole, thiazole and oxazole derivatives and their use for the manufacture of a medicament for the treatment and/or prevention of pollakiuria or urinary incontinence |
| 04/15/2004 | US20040073036 Substituted alkyl amido piperidines |
| 04/15/2004 | US20040072987 3,4-Alkylenedioxythiophene compounds and polymers thereof |
| 04/15/2004 | US20040072833 Antidepressants; anxiolytic agents; eating disorders; antiulcer agents; drug abuse; Alzheimer's disease |
| 04/15/2004 | US20040072370 Reacting pyrrole, indole with p-dimethylaminobenzaldehyde; forming chromogens |
| 04/15/2004 | CA2500145A1 Process and intermediates for the preparation of the thienopyrrole derivatives |
| 04/15/2004 | CA2498843A1 Process and intermediates for the preparation of thienopyrrole derivatives |
| 04/14/2004 | EP1406901A1 Quinuclidines-substituted-multi-cyclic-heteroaryls for the treatment of disease |
| 04/14/2004 | EP1202994B1 New compounds |
| 04/14/2004 | EP1042315B1 Cyclic imide-substituted pyridylalkane, alkene, and alkine carboxamides useful as cytostatic and immunosuppressive agents |
| 04/14/2004 | EP1040097B1 Potassium channel openers |
| 04/14/2004 | EP1039917B1 Pharmaceutical composition comprising ticlopidine and ginkgo biloba extract |
| 04/14/2004 | CN1489579A 7-heterocyclyl quinoline and thieno[2,3,-b] pyridine derivatives useful as antagonists of gonadotropin releasing hormone |
| 04/14/2004 | CN1489467A Pharmacentical formulation comprising pyrazolo[4,3-d] pyrimdine and endothelin receptor antagonists or thienopyrimidines and endothelin receptor antagonists |
| 04/14/2004 | CN1145614C Irreversible inhibitors of tyrosine kinases, its pharmaceutical use and medicine composition thereof |
| 04/08/2004 | WO2004029212A2 In vivo gene silencing by chemically modified and stable sirna |
| 04/08/2004 | WO2004029060A1 Novel herbicides, usage thereof, novel thienopyrimidine derivatives, intermediates of the same, and process for production thereof |
| 04/08/2004 | WO2004028459A2 Piperidine derivatives |
| 04/08/2004 | WO2004016604A3 Azabicyclic compounds are central nervous system active agents |
| 04/08/2004 | WO2003082832A3 Anxiolytic agents with reduced sedative and ataxic effects |
| 04/08/2004 | WO2003078647A3 Aza-benzothiopyranoindazoles with antitumor activity |
| 04/08/2004 | WO2003035652A9 A PROCESS FOR PREPARING ENANTIOMERICALLY PURE α-PHENYL-α-(6,7-DIHYDRO-4H-THIENO[3,2-C]PYRIDIN-5-YL)-ACETIC ACID DERIVATIVES |
| 04/08/2004 | US20040067946 Phthalatyinone-piperidino-derivatives as pde4 inhibitors |
| 04/08/2004 | US20040067936 Process for preparation of hydrates of olanzapine and their conversion into crystalline forms of olanzapine |
| 04/08/2004 | US20040067872 Novel mono- and di-fluorinated benzothiepine compouds as inhibitors of apical sodium co-dependent bile acid transport (ASBT) and taurocholate uptake |
| 04/08/2004 | US20040067199 Conjugates with radionuclides; radiotherapy; tumor diagnosis |
| 04/08/2004 | CA2500224A1 In vivo gene silencing by chemically modified and stable sirna |
| 04/08/2004 | CA2500207A1 Novel herbicide, method of using the same, novel substituted thienopyrimidine derivative and intermediate thereof, and process for producing the same |
| 04/08/2004 | CA2499876A1 Piperidine derivatives |
| 04/07/2004 | EP1405852A1 Diamine derivatives |
| 04/07/2004 | EP1404683A2 Polymerisable charge transport compounds |
| 04/07/2004 | EP1404682A1 Method of inhibiting ptp 1b and/or t-cell ptp and/or other ptpases with an asp residue at position 48 |
| 04/07/2004 | EP1404681A1 Process for the preparation of tetrahydrothieno [3,2-c] pyridine derivatives |
| 04/07/2004 | EP1404341A1 Active substance combination for medicamentous therapy of nicotine dependency |
| 04/07/2004 | EP1317459B1 Bicyclic pyrrolyl amides as glucogen phosphorylase inhibitors |
| 04/07/2004 | CN1487943A Process for preparing clopidogrel |
| 04/07/2004 | CN1487933A Pyrazole compounds useful as protein kinase inhibitors |
| 04/07/2004 | CN1487831A Tetrahydro-(benzo or thieno)-azepine-pyrazine and triazine derivatives as mGluR1 antagonists |
| 04/07/2004 | CN1144806C Thienopyrimidines compound |
| 04/07/2004 | CN1144793C Polar-substituted hydrocarbons |
| 04/07/2004 | CN1144788C Bicycle vasporession agonists |
| 04/06/2004 | US6716995 Design and synthesis of advanced NLO materials for electro-optic applications |
| 04/06/2004 | US6716991 Process for preparing a substituted pyrazolyl benzenesulfonamide for the treatment of inflammation |
| 04/06/2004 | US6716979 Including coumarins, rhodamines, and rhodols that incorporate additional fused aromatic rings; absorb at a longer wavelength than structurally similar dyes that do not possess the fused aromatic rings; dye conjugates; reactive dyes |
| 04/06/2004 | CA2124306C Quinazolinone derivatives |
| 04/01/2004 | WO2004026879A1 Clopidogrel |
| 04/01/2004 | WO2004026878A1 6,7-DIHYDRO-5H-PYRAZOLO[1,2-a]PYRAZOL-1-ONES WHICH CONTROL INFLAMMATORY CYTOKINES |
| 04/01/2004 | WO2004006933A3 Crystal forms of olanzapine and processes for their preparation |
| 04/01/2004 | WO2003080596A3 Bicyclic fused pyridinyl amides and advantageous compositions thereof for use as fungicides |
| 04/01/2004 | US20040063943 Phosphodiesterase inhibitor; cardiovascular disorders; sexual disorders |
| 04/01/2004 | US20040063889 Copolymer composition having pigment like properties |
| 04/01/2004 | US20040063753 N-acetoamino-4-one-Pyridine derivatives are used as Lp-PLA2 (lipoprotein Associated Phospholipase A2) enzyme inhibitor |
| 04/01/2004 | US20040063731 Pharmaceutical formulation comprising pyrazolo[4,3-d]pyrimidines and endothelin receptor antagonists or thienopyrimidines and endothelin receptor antagonists |